These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 24681125)

  • 1. One Health approach to Rift Valley fever vaccine development.
    Kortekaas J
    Antiviral Res; 2014 Jun; 106():24-32. PubMed ID: 24681125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
    Kortekaas J; de Boer SM; Kant J; Vloet RP; Antonis AF; Moormann RJ
    Vaccine; 2010 Jun; 28(27):4394-401. PubMed ID: 20434545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of three candidate Rift Valley fever vaccines in sheep.
    Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
    Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
    Ikegami T
    Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking the chain: Rift Valley fever virus control via livestock vaccination.
    Bird BH; Nichol ST
    Curr Opin Virol; 2012 Jun; 2(3):315-23. PubMed ID: 22463980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
    Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rift valley fever vaccines.
    Ikegami T; Makino S
    Vaccine; 2009 Nov; 27 Suppl 4():D69-72. PubMed ID: 19837291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of two next-generation Rift Valley fever vaccines.
    Kortekaas J; Oreshkova N; van Keulen L; Kant J; Bosch BJ; Bouloy M; Moulin V; Goovaerts D; Moormann RJ
    Vaccine; 2014 Sep; 32(39):4901-8. PubMed ID: 25050973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
    Morrill JC; Mebus CA; Peters CJ
    Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
    Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
    Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
    Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.
    de Boer SM; Kortekaas J; Antonis AF; Kant J; van Oploo JL; Rottier PJ; Moormann RJ; Bosch BJ
    Vaccine; 2010 Mar; 28(11):2330-9. PubMed ID: 20056185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches to develop Rift Valley fever vaccines.
    Indran SV; Ikegami T
    Front Cell Infect Microbiol; 2012; 2():131. PubMed ID: 23112960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-like particle-based countermeasures against Rift Valley fever virus.
    Koukuntla R; Mandell RB; Flick R
    Zoonoses Public Health; 2012 Sep; 59 Suppl 2():142-50. PubMed ID: 22958258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
    Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
    Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheep.
    Weingartl HM; Nfon CK; Zhang S; Marszal P; Wilson WC; Morrill JC; Bettinger GE; Peters CJ
    Vaccine; 2014 Apr; 32(20):2345-9. PubMed ID: 24462482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever.
    Warimwe GM; Gesharisha J; Carr BV; Otieno S; Otingah K; Wright D; Charleston B; Okoth E; Elena LG; Lorenzo G; Ayman el-B; Alharbi NK; Al-dubaib MA; Brun A; Gilbert SC; Nene V; Hill AV
    Sci Rep; 2016 Feb; 6():20617. PubMed ID: 26847478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.
    Rissmann M; Ulrich R; Schröder C; Hammerschmidt B; Hanke D; Mroz C; Groschup MH; Eiden M
    Vaccine; 2017 Jan; 35(4):655-662. PubMed ID: 28012779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.
    Bird BH; Maartens LH; Campbell S; Erasmus BJ; Erickson BR; Dodd KA; Spiropoulou CF; Cannon D; Drew CP; Knust B; McElroy AK; Khristova ML; Albariño CG; Nichol ST
    J Virol; 2011 Dec; 85(24):12901-9. PubMed ID: 21976656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.